When we tested the putative angiogenic potential of the three chemokines, an increasing dose-response in the tubule formation assay was found for CXCL1 and CXCL5, even at lower concentrations than those required to induce myeloma growth (Fig. 3E). Here, CXCL5 is linked to plasma cell myeloma.